×

img Accessibility Controls

Research Projects Banner

Research Projects

Genotypic analysis and invitro evaluation of antimicrobials against Acanthamoeba keratitis

Implementing Organization

Principal Investigator
Dr. Dhanurekha Lakshmipathy
sankara Nethralaya (Medical Research Foundation), Chennai, Tamil Nadu
CO-Principal Investigator
Dr. Appakkudal R Anand
sankara Nethralaya (Medical Research Foundation), Chennai, Tamil Nadu -600006, Dr. shweta s Agarwal, sankara Nethralaya (Medical Research Foundation), Chennai, Tamil Nadu -600006

Project Overview

Acanthamoeba keratitis (AK) is a life threatening infection of the cornea. Acanthamoeba gains access to a disrupted corneal epithelium either during trauma or surgery or usage of contact lens. In recent decades, the risk of getting AK has increased because of the increased proportion of contact lens wearers. AK is often misdiagnosed and treated as herpetic, bacterial, or mycotic keratitis, as many signs and symptoms may look similar to other kinds of keratitis. The routine Laboratory investigations includes- examination of double walled fluorescing cyst under fluorescent microscope (may lack sensitivity) and culture in non nutrient agar (longer incubation period). Moreover, Acanthamoeba has the ability to transform rapidly into dormant cyst forms, which may resist recommended levels of antimicrobial chemotherapy. Therefore, Exploration of understanding the virulence factors leading to devasting infection, genotypic identification of various strains of Acanthamoeba species and pathophysiology to find out various therapeutic interventions for AK which is almost impossible to establish a correlation between in vitro and in vivo efficacies is crucial to combat misdiagnosis and ineffective treatment modalities. Thus, the proposed study focuses on Molecular identification by genotyping of Acanthamoeba species leading to AK and invitro evaluation of antimicrobials against Trophozoites and cysts of genotyped Acanthamoeba clinical isolates to explore the pattern of drug resistance exhibited by various genotypes revealed from the study and paving way for the clinicians for appropriate management of AK.

Source

Source
Anusandhan National Research Foundation/science and Engineering Research Board (sERB), DsT 2023-24
Funding Organization
Quick Information
Area of Research
Life Sciences & Biotechnology
Start Date
2023
End Date
2026
Status
Ongoing
Contact
drdhanu@snmail.org
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
00
Publications
00
No. of Patents
Filed : 00
Grant : 00
arrowtop
Latest Updates
Loading…